Cargando…
Co-Clinical Trials: An Innovative Drug Development Platform for Cholangiocarcinoma
Cholangiocarcinoma (CCA), a group of malignancies that originate from the biliary tract, is associated with a high mortality rate and a concerning increase in worldwide incidence. In Thailand, where the incidence of CCA is the highest, the socioeconomic burden is severe. Yet, treatment options are l...
Autores principales: | Balasubramanian, Brinda, Venkatraman, Simran, Myint, Kyaw Zwar, Janvilisri, Tavan, Wongprasert, Kanokpan, Kumkate, Supeecha, Bates, David O., Tohtong, Rutaiwan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7826774/ https://www.ncbi.nlm.nih.gov/pubmed/33440754 http://dx.doi.org/10.3390/ph14010051 |
Ejemplares similares
-
Dysregulation of microRNA in cholangiocarcinoma identified through a meta-analysis of microRNA profiling
por: Likhitrattanapisal, Somsak, et al.
Publicado: (2020) -
Targeting FGFRs Using PD173074 as a Novel Therapeutic Strategy in Cholangiocarcinoma
por: Balasubramanian, Brinda, et al.
Publicado: (2023) -
Effect of Combining EGFR Tyrosine Kinase Inhibitors and Cytotoxic Agents on Cholangiocarcinoma Cells
por: Boonsri, Boonyakorn, et al.
Publicado: (2021) -
Downregulation of ABCA1 and ABCG1 transporters by simvastatin in cholangiocarcinoma cells
por: Seeree, Pattaya, et al.
Publicado: (2019) -
RTK25: A Comprehensive Molecular Profiling Strategy in Cholangiocarcinoma Using an Integrated Bioinformatics Approach
por: Balasubramanian, Brinda, et al.
Publicado: (2021)